October 17, 2008
Among patients with diabetes and asymptomatic peripheral arterial disease, aspirin did not reduce primary fatal and non-fatal cardiovascular events compared with placebo, according to a study by Jill Belch, MD, of the University of Dundee in Scotland, and colleagues online in BMJ. Reported at MedPage Today.